Beneficial effects of empagliflozin on hematocrit levels in a patient with severe anemia.

Daru · 2021 · PMC8602545 · PMID 34545553

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes pmc-license-ref CC BY issue-copyright-statement © Springer Nature Switzerland AG 2021 Introduction SGLT2 (sodium-glucose cotransporter) inhibitors as a class of drugs have made an accidental, but extremely significant breakthrough in cardiology.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.